Hodgkin lymphoma outcomes in the novel agent era, genomic safe harbors for precision T cell engineering, and a transcriptomic atlas to map imatinib resistance in CML
Blood Podcast
00:00
The Role of PD-1 Inhibitors in the Treatment of Classic Hodgkin Lymphoma
Treatment with PD-1 inhibitors prior to transplant may be especially beneficial. More work is needed to determine the optimal place for Brintoximab and PD-1 inhibitor in the treatment of classic Hodgkin lymphoma. The next research article is entitled Novel Extrogenic Genomic Safe Arbors for Precise Therapeutic T-Cell Engineering.
Transcript
Play full episode
